The recent pullback for stocks, or as Goldman Sachs refers to it, that “warp speed correction on the road to 3,600,” (their S&P 500 target), looks to be on pause for Monday, as deal news and vaccine optimism fires up markets.
While we are nowhere near out of the woods with COVID-19, there is growing chatter on Wall Street about life after the virus and how to invest. Christopher Smart, chief global strategist and head of the Barings Investment Institute, tells his clients they need to answer three questions before proceeding:
“Is COVID-19 over? (Yes). Will next year be ‘normal’ (Yes), and What’s the best way to play the next cycle?” Navigate secular trends that the pandemic has speeded up — technology that will reshape business, rising concern for climate change, and new patterns of living, says Smart.
Echoing those sentiments, our call of the day from AB Bernstein lays out where investors should position themselves over the next three to five years.
“We think that long-run equity sector positioning has to be assessed across several dimensions, some of which are linked to the macro policy outlook and some to how demands of investors will change post COVID,” says a team of strategists led by Inigo Fraser Jenkins.
Bernstein says sector performance will be shaped by the following: real rates staying low or negative for a long time; strategic policy shifts on tax, buybacks and labor bargaining power; valuation spreads that are extreme levels and changing demands of investors as they face post-pandemic challenges; and growing interest in ESG investing (Environmental, Social and Governance).
Wall Street stocks
COMP,
+2.32%
SPX,
+1.71%
DJIA,
+1.37%
are higher
NQ00,
+2.44%
European equities
SXXP,
+0.14%
are mixed, while Asian stocks finished in the green.
Amazon.com
AMZN,
+1.35%
plans to hire 100,000 U.S. and Canadian workers, with starting wages at $15 an hour and $1,000 sign-on bonuses in some cities.
Microsoft
MSFT,
+2.03%
said on Sunday that its bid for TikTok had been turned down, with no explanation why. And after reports that Oracle
ORCL,
+5.83%
would become a “trusted tech partner” for TikTok parent ByteDance, a Chinese state-affiliated news source said that sale won’t be happening. Microsoft shares are down 0.5% and Oracle shares are up 8%.
Nvidia
NVDA,
+6.39%
shares are climbing after Japan technology conglomerate SoftBank
9984,
+8.95%
announced a $40 billion cash-and-stock deal to sell microprocessor designer Arm Holdings to the chip maker.
Nikola issued a detailed rebuttal over what it terms was a “false and misleading” report that called the electric-truck maker as a “fraud.” Shares are down another 3% after plunging last week.
Albert Bourla, the chief executive of Pfizer
PFE,
+3.03%,
said on Sunday that the drugmaker should know if its COVID-19 vaccine candidate will work by the end of October — and if approved, it could be distributed in the U.S. by the end of the year. Pfizer is joining with German drugmaker BioNTech
BNTX,
+4.79%
on that drug.
The University of Oxford said on Saturday it would resume a trial for the coronavirus vaccine candidate it is developing with AstraZeneca
AZN,
+0.81%
AZN,
-0.34%.
That comes days after the study was halted following a U.K. patient falling ill.
Need to Know starts early and is updated until the opening bell, but sign up here to get it delivered once to your email box. The emailed version will be sent out at about 7:30 a.m. Eastern.
The central bank gathering could offer details on how the Fed will put its new average inflation targeting framework into practice against a backdrop of deflationary pressures from the COVID-19 pandemic.
By using this site you agree to the
Subscriber Agreement & Terms of Use Updated 03/26/2020
Privacy Notice and
Cookie Notice.
Intraday Data provided by FACTSET and subject to terms of use.
Historical and current end-of-day data provided by FACTSET.
All quotes are in local exchange time.
Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.
Intraday data delayed at least 15 minutes or per exchange requirements.
